Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus

被引:86
|
作者
Perciaccante A. [1 ]
Fiorentini A. [1 ]
Paris A. [1 ]
Serra P. [1 ]
Tubani L. [2 ]
机构
[1] III Clinica Medica, Department of Clinical Medicine, University La Sapienza, Rome
[2] Medicina Interna E, Department of Clinical Medicine, University La Sapienza, Rome
关键词
Insulin Resistance; Heart Rate Variability; Impaired Glucose Tolerance; Impaired Fasting Glucose; Autonomic Activity;
D O I
10.1186/1471-2261-6-19
中图分类号
学科分类号
摘要
Background: In type 2 diabetes mellitus both insulin resistance and hyperglycemia are considered responsible for autonomic dysfunction. The relation between the autonomic activity, impaired fasting glycemia and impaired glucose tolerance is, however, unclear. The purpose of this study was to evaluate and compare the circadian autonomic activity expressed as heart rate variability (HRV) measured by 24-hours ECG recording in insulin resistant subjects (IR) with characteristics as follow: IR subjects with normal oral glucose tolerance test results, IR subjects with impaired fasting glucose, IR subjects with impaired glucose tolerance and subjects with type 2 diabetes mellitus. Methods: Eighty Caucasian insulin resistant subjects (IR) and twenty five control subjects were recruited for the study. IR subjects were divided into four groups according to the outcoming results of oral glucose tests (OGTTs): IR subjects with normal glucose regulation (NGR), IR subjects with impaired fasting glycemia (IFG), IR subjects with impaired glucose tolerance (IGT) and subjects with type 2 diabetes mellitus (DM). Autonomic nervous activity was studied by 24-hours ECG recording. Heart rate variability analysis was performed in time and frequency domains: SDNN, RMS-SD, low frequency (LF) and high frequency (HF) were calculated. Results: The total SDNN showed statistically significant reduction in all four groups with insulin resistant subjects (IR) when compared to the control group (p <0,001). During night LF normalized units (n.u.) were found to be higher in all four groups including IR subjects than in the control group (all p < 0,001) and subjects with normal glucose regulation (NGR), with impaired fasting glycemia (IFG) and with impaired glucose tolerance (IGT) were found to have higher LF n.u. than those in the type 2 diabetes mellitus group. The linear regression model demonstrated direct association between LF values and the homeostasis model assessment-index (HOMA-1), in the insulin resistant group (r = 0,715, p <0,0001). Conclusion: The results of our study suggest that insulin resistance might cause global autonomic dysfunction which increases along with worsening glucose metabolic impairment. The analysis of sympathetic and parasympathetic components and the sympathovagal balance demonstrated an association between insulin resistance and sympathetic over-activity, especially during night. The results indicated that the sympathetic over-activity is directly correlated to the grade of insulin resistance calculated according to the HOMA-1. Since increased sympathetic activity is related to major cardiovascular accidents, early diagnosis of all insulin resistant patients should be contemplated. © 2006 Perciaccante et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [21] Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria
    Elbert, Alicia
    Schreier, Laura
    Galli, Cinthia
    Beresan, Hugo
    Lopez, Graciela
    Traversa, Mercedes
    Berg, Gabriela
    JOURNAL OF RENAL NUTRITION, 2006, 16 (04) : 300 - 303
  • [22] Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes
    Pixner, Thomas
    Chaikouskaya, Tatsiana
    Lauth, Wanda
    Zimmermann, Georg
    Moerwald, Katharina
    Lischka, Julia
    Furthner, Dieter
    Awender, Elisabeth
    Geiersberger, Sabine
    Maruszczak, Katharina
    Forslund, Anders
    Anderwald, Christian-Heinz
    Cadamuro, Janne
    Weghuber, Daniel
    Bergsten, Peter
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [23] Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance
    Succurro, Elena
    Marini, Maria Adelaide
    Riccio, Alessia
    Fiorentino, Teresa Vanessa
    Perticone, Maria
    Sciacqua, Angela
    Andreozzi, Francesco
    Sesti, Giorgio
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 194
  • [24] Pulsatile insulin secretion in type 2 diabetes, impaired glucose tolerance and healthy subjects
    Ritzel, R
    Schulte, M
    Porksen, N
    Juhl, CB
    Schmitz, O
    Schmiegel, WH
    Nauck, MA
    DIABETES, 2000, 49 : A253 - A253
  • [25] Autonomic Neuropathy and Endothelial Dysfunction in Patients With Impaired Glucose Tolerance or Type 2 Diabetes Mellitus
    Tiftikcioglu, Bedile Irem
    Bilgin, Sule
    Duksal, Tarik
    Kose, Sukran
    Zorlu, Yasar
    MEDICINE, 2016, 95 (14)
  • [26] Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose
    Gorter, K. J.
    Janssen, P. G. H.
    Stolk, R. P.
    Rutten, G. E. H.
    DIABETOLOGIA, 2006, 49 : 226 - 227
  • [27] Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose
    Wu, Jin-Shang
    Yang, Yi-Ching
    Lin, Thy-Sheng
    Huang, Ying-Hsiang
    Chen, Jia-Jin
    Lu, Feng-Hwa
    Wu, Chih-Hsing
    Chang, Chih-Jen
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (10): : 3885 - 3889
  • [28] Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose
    Festa, A
    D'Agostino, R
    Hanley, AJG
    Karter, AJ
    Saad, MF
    Haffner, SM
    DIABETES, 2004, 53 (06) : 1549 - 1555
  • [29] Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus
    Delorme, S
    Chiasson, JL
    CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) : 184 - 189
  • [30] Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population
    Guerrero-Romero, Fernando
    Violante, Rafael
    Rodriguez-Moran, Martha
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2009, 23 (04) : 363 - 369